Enabling population protein dynamics through Bayesian modeling

Area of Science:

• Biochemistry
• Pharmacology
• Computational Biology

Background:

• Understanding protein dynamics (turnover) in patients is crucial for disease research and drug development.
• Existing experimental and computational methods offer insights into protein turnover in vivo.
• A gap exists in modeling population-level protein dynamics and inter-individual variability.

Purpose of the Study:

• To introduce a novel Bayesian modeling approach for population protein dynamics.
• To accurately capture protein turnover within a patient cohort.
• To account for inter-individual variability in protein dynamics.

Main Methods:

• Developed a novel modeling approach using Bayesian statistics.
• Inspired by population pharmacokinetic modeling principles.
• Validated the approach using two independent datasets.

Main Results:

• The proposed models accurately capture protein turnover within a cohort.
• The models successfully account for inter-individual variability.
• Demonstrated the utility of the approach with real-world data.

Conclusions:

• Population pharmacokinetic-inspired models can effectively characterize protein dynamics.
• This approach facilitates comparative studies for disease biomarker discovery.
• Enables deeper insights into biological processes and drug efficacy.